Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wiesner

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nature Biotechnology|July 29, 2020
Isolating live cell clones from barcoded populations using CRISPRa-inducible reportersChristian Umkehrer, Felix Holstein, Laura Formenti, et al.
Cell Reports|October 14, 2020
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal MelanomaAmanda R Moore, Leili Ran, Youxin Guan, et al.
Cell Reports|March 1, 2018
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal MelanomaAmanda R Moore, Leili Ran, Youxin Guan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 2, 2022
The Radical Anion, Dianion and Electron Transport Properties of TetraiodotetraazapentaceneThomas Wiesner, Zhu Wu, Jie Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomasKlaus G Griewank, Henrike Westekemper, Rajmohan Murali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nestsHeinz Kutzner, Gisela Metzler, Zsolt Argenyi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2016
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue neviInga Möller, Rajmohan Murali, Hansgeorg Müller, et al.
Nature Communications|September 15, 2019
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanomaJohannes Griss, Wolfgang Bauer, Christine Wagner, et al.
The New England Journal of Medicine|November 19, 2010
Mutations in GNA11 in uveal melanomaCatherine D Van Raamsdonk, Klaus G Griewank, Michelle B Crosby, et al.
Nature Genetics|September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumorsWilliam Lee, Sewit Teckie, Thomas Wiesner, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|July 29, 2020
Isolating live cell clones from barcoded populations using CRISPRa-inducible reportersChristian Umkehrer, Felix Holstein, Laura Formenti, et al.
Cell Reports|October 14, 2020
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal MelanomaAmanda R Moore, Leili Ran, Youxin Guan, et al.
Cell Reports|March 1, 2018
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal MelanomaAmanda R Moore, Leili Ran, Youxin Guan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 2, 2022
The Radical Anion, Dianion and Electron Transport Properties of TetraiodotetraazapentaceneThomas Wiesner, Zhu Wu, Jie Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomasKlaus G Griewank, Henrike Westekemper, Rajmohan Murali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nestsHeinz Kutzner, Gisela Metzler, Zsolt Argenyi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2016
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue neviInga Möller, Rajmohan Murali, Hansgeorg Müller, et al.
Nature Communications|September 15, 2019
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanomaJohannes Griss, Wolfgang Bauer, Christine Wagner, et al.
The New England Journal of Medicine|November 19, 2010
Mutations in GNA11 in uveal melanomaCatherine D Van Raamsdonk, Klaus G Griewank, Michelle B Crosby, et al.
Nature Genetics|September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumorsWilliam Lee, Sewit Teckie, Thomas Wiesner, et al.
Pageof 8